All Things Newz
Law \ Legal

Similis Bio And Blau Farmaceutica Enter Into Development And License Agreement For Biosimilars – Life Sciences, Biotechnology & Nanotechnology


To print this article, all you need is to be registered or login on

On October 25, 2022, JSR Life Sciences and Blau Farmaceutica
announced that Similis Bio, JSR Life Sciences’s business unit
focused on biosimilar development, has signed its first development
and license agreement with Blau Farmaceutica, a Brazilian
pharmaceutical company. According to the press release, the agreement contemplates a
multi-product and multi-year deal to develop products and license
intellectual property for four assets targeting indications in
oncology, inflammation and blood disorders.

Under the agreement, Simils Bio will provide full processes and
associated intellectual property for technology transfer to Blau,
which will utilize the intellectual property for GMP manufacturing
and clinical development, and seek regulatory approval. Blau has
exclusive worldwide rights and intends to market independently in
the U.S., and to partner with local organizations in other regions.
The agreement is structured with upfront payments and long-term
royalties upon commercial approval for sale, and the parties expect
the total value of the contract to exceed $100 million. The parties
did not disclose additional financial terms.

The content of this article is intended to provide a general
guide to the subject matter. Specialist advice should be sought
about your specific circumstances.

POPULAR ARTICLES ON: Food, Drugs, Healthcare, Life Sciences from United States

Final Rules Fix Family Glitch

Seyfarth Shaw LLP

The final regulations (available here) implement aspects of the IRS’s proposed regulations from earlier this year. Some notable highlights, which are effective for tax years beginning after December 31, 2022, are…


Source link

Related posts

Cases Not Entitled To The Occupational Accident Regime In Vietnam In 2022 – Health & Safety

Expanded Medicare Telehealth Coverage For Opioid Use Disorder Treatment Services Furnished By Opioid Treatment Programs – Healthcare

Diritto D’autore E Internet: Il Tribunale Di Milano Inibisce Il Servizio Di DNS Di Cloudflare – Copyright